Rheumatology · Inflammatory Myopathies
The facts most likely to be tested
Polymyositis presents with symmetric, proximal muscle weakness involving the shoulders and hips without the characteristic skin findings of dermatomyositis.
Laboratory evaluation reveals elevated creatine kinase (CK), aldolase, and AST/ALT levels reflecting muscle fiber damage.
The most specific autoantibody associated with polymyositis is the anti-Jo-1 antibody, which is also linked to interstitial lung disease and mechanic's hands.
The gold standard for definitive diagnosis is a muscle biopsy showing endomysial inflammation with CD8+ T-lymphocytes invading non-necrotic muscle fibers.
Electromyography (EMG) findings typically demonstrate myopathic changes including small, polyphasic motor unit potentials and fibrillation potentials.
First-line pharmacologic therapy for polymyositis is high-dose systemic corticosteroids.
Patients with polymyositis have an increased risk of underlying malignancy, necessitating age-appropriate cancer screening.
Vignette unlocked
A 52-year-old woman presents with a 3-month history of progressive difficulty rising from a chair and lifting her arms to brush her hair. She denies any skin rashes, photosensitivity, or joint pain. Physical examination reveals symmetric 4/5 strength in the proximal upper and lower extremities with normal sensation and reflexes. Laboratory studies show a creatine kinase level of 2,400 U/L and a positive anti-Jo-1 antibody. A muscle biopsy is performed to confirm the diagnosis.
Which of the following histopathologic findings is most likely to be seen on the muscle biopsy?
Endomysial inflammation with CD8+ T-lymphocytes
The patient's presentation of proximal muscle weakness and elevated CK is classic for polymyositis, which is pathologically characterized by endomysial inflammation mediated by CD8+ T-cells.
Full handout
High yield triage
Etiology / Epidemiology
Idiopathic inflammatory myopathy; most common in adults 30-50 years old, specifically females and African Americans.
Clinical Manifestations
Presents with symmetrical proximal muscle weakness (shoulders/hips) and Gowers sign; notably lacks the skin findings of dermatomyositis.
Diagnosis
The muscle biopsy is the gold standard; labs show elevated creatine kinase (CK) and positive anti-Jo-1 antibodies.
Treatment
High-dose corticosteroids are the first-line treatment; avoid statins if myopathy is severe.
Prognosis
High risk of interstitial lung disease; monitor pulmonary function tests to prevent respiratory failure.
Full handout
Epidemiology & Etiology
Polymyositis is an autoimmune condition characterized by T-cell mediated muscle injury. It is significantly more prevalent in females and patients of African descent. Onset typically occurs between the 3rd and 5th decades of life.
Pertinent Anatomy
The disease primarily targets the proximal skeletal muscles of the shoulder and pelvic girdles. Involvement of the pharyngeal and esophageal muscles can lead to dysphagia and aspiration risk.
Pathophysiology
The process involves CD8+ T-cell mediated cytotoxicity against muscle fibers. This leads to endomysial inflammation and subsequent myofiber necrosis. Chronic inflammation results in progressive muscle atrophy and weakness.
Clinical Manifestations
Patients present with insidious, symmetrical proximal muscle weakness making it difficult to climb stairs or rise from a chair, often demonstrating Gowers sign. Unlike dermatomyositis, there are no pathognomonic skin rashes like Gottron papules or heliotrope rash. Dysphagia and respiratory muscle weakness are critical red flags requiring immediate evaluation.
Diagnosis
The muscle biopsy is the definitive diagnostic test, showing endomysial inflammation. Serum creatine kinase (CK) is typically elevated 5-50 times the upper limit of normal. Anti-Jo-1 antibodies (anti-synthetase syndrome) are highly specific and associated with lung disease.
Treatment
High-dose corticosteroids (e.g., prednisone) are the first-line therapy to suppress inflammation. If refractory, methotrexate or azathioprine are added as steroid-sparing agents. Avoid statins during the acute phase to prevent exacerbation of myotoxicity.
Prognosis
The primary cause of mortality is interstitial lung disease and associated respiratory failure. Patients require serial pulmonary function tests (PFTs) and chest imaging to monitor for restrictive lung patterns.
Differential Diagnosis
Dermatomyositis: Presence of pathognomonic skin rashes
Inclusion Body Myositis: Distal muscle involvement and older males
Polymyalgia Rheumatica: Pain and stiffness without significant muscle weakness
Hypothyroidism: Elevated CK with delayed deep tendon reflexes
Drug-induced myopathy: History of recent statin or glucocorticoid initiation